Moderna shares jumped after the biotechnology company reported higher-than-expected sales of its Covid-19 vaccine and backed ...

Nov 12 (Reuters) - Novavax (NVAX.O), opens new tab cut its annual revenue forecast on Tuesday, citing lower-than-expected ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

Researchers investigate how public trust in the science of COVID-19 vaccines has changed in the United States.

Novavax (NASDAQ:NVAX) shares lost ~12% in the premarket on Tuesday after the Gaithersburg, MD-based biotech, with its Q3 2024 ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

As of late October, the CDC recommends a second dose of the 2024-2025 COVID-19 vaccine for at-risk groups. Here's what you ...

A jury has awarded more than $12 million to a woman who lost her job at a Michigan insurance company after declining to get a COVID-19 vaccination ...

Older Americans are being urged to get the COVID-19 vaccine again, but it depends on when they received their last dose.

A study conducted by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the ...

The Centers for Disease Control and Prevention's (CDC's) 2024-2025 COVID-19 vaccine immunization schedule advises, in the ...

In conclusion, this report presents the first known cases of TTP associated with an inactivated COVID-19 vaccine and ...